Utilizing Tumor and Plasma Liquid Biopsy in Treatment Decision Making for an Estrogen Receptor-Positive Advanced Breast Cancer PatientBing Xu, Brian Leyland‐Jones, Amy Krie et al.|Cureus|2017Cited by 15
Down’s Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical RelationshipNandini Dey, Brian Leyland‐Jones, Amy Krie et al.|International Journal of Molecular Sciences|2017Cited by 9
Abstract 4591: Estrogen receptor-positive breast cancer: from genomic landscape to treatment approachPradip De, Brian Leyland‐Jones, Jennifer Carlson et al.|Cancer Research|2016Cited by 1
Abstract 1980: Identification of the transcription factor ZNF217 in ER+ subset of BC: A functional relationship with the PI3K-AKT-mTOR pathwayNandini Dey, Brian Leyland‐Jones, Casey Williams et al.|Cancer Research|2015Cited by 0
Value of sequencing-guided treatment for patients with advanced malignancies.Casey Williams, Brian Leyland‐Jones, Robert B. Goldberg et al.|Journal of Clinical Oncology|2016Cited by 0